title: Case report: Successful treatment of cutaneous leishmaniasis caused by Leishmania aethiopica with liposomal amphothericin B in an immunocompromised traveler returning from Eritrea.
abstract: Cutaneous leishmaniasis caused by Leishmania aethiopica is rarely encountered outside disease-endemic areas and there have been no clinical trials evaluating its pharmacotherapy. We describe the treatment of cutaneous leishmaniasis caused by L. aethiopica using liposomal amphothericin B in an immunocompromised traveler returning from Eritrea.
authors.affiliation: Institut für Tropenmedizin, Medizinische Klinik, Onkologie, Hämatologie, Klinische Immunologie, Rheumatologie und Pulmonologie, Infektionskrankheiten Eberhard Karls Universität, Wilhelmstrasse 27, Tübingen, Germany. philipp.zanger@med.uni-tuebingen.de
authors.forename: Philipp
authors.initials: P
authors.lastname: Zanger
authors.forename: Ina
authors.initials: I
authors.lastname: Kötter
authors.forename: Armin
authors.initials: A
authors.lastname: Raible
authors.forename: Tesfaye
authors.initials: T
authors.lastname: Gelanew
authors.forename: Gabriele
authors.initials: G
authors.lastname: Schönian
authors.forename: Peter G
authors.initials: PG
authors.lastname: Kremsner
mesh_terms: D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use*; D019017:Eritrea; D006801:Humans; D016867:Immunocompromised Host; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy* / Q000469:parasitology; D008297:Male; D014195:Travel
chemical_list: C068538:liposomal amphotericin B; D000666:Amphotericin B